Login to Your Account



Analyst: 'Not Out of the Woods'

Macro Woes Could Impact Biotech Financing, M&A

By Trista Morrison


Monday, August 22, 2011
The picture isn't pretty: Stocks are down, unemployment is up and Standard & Poor's lowered its long-term sovereign credit rating on the U.S. to AA+ from AAA. Other downgrades followed, including Berkshire Hathaway and a slew of municipal bonds. Consumer spending dropped in June for the first time in about two years, prompting macroeconomists to lower their GDP estimates.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription